Research Article
Splenectomy versus Partial Splenic Embolization for Massive Splenomegaly Secondary to Hepatitis B-Related Liver Cirrhosis: A Case-Control Study
Table 1
Background characteristics of enrolled patients.
| | Parameters | Control group () | SP group () | PSE group () | value |
| | Child-Pugh grade (A : B : C) | 54 : 11 : 0 | 54 : 11 : 0 | 54 : 11 : 0 | 1.0000 | | Gender (M : F) | 43 : 22 | 45 : 20 | 44 : 21 | 0.9321 | | Age (y) | 45.3 ± 7.1 | 46.1 ± 8.7 | 46.4 ± 9.4 | 0.7771 | | WBC count (/mm3) | 3.75 ± 0.88 | 2.81 ± 1.02 | 3.29 ± 0.95 | <0.001 | | PLT count (103/mm3) | 7.3 ± 2.5 | 3.6 ± 2.7 | 4.5 ± 2.4 | <0.001 | | HBV DNA level (log10) | 4.27 ± 0.91 | 4.16 ± 0.85 | 4.34 ± 0.88 | 0.5025 | | Antiviral protocol | | | | 0.9806 | | Lamivudine | 29 | 28 | 28 | | | Adefovir plus lamivudine | 6 | 5 | 5 | | | Entecavir plus lamivudine | 2 | 2 | 1 | | | Spleen weight (g) | 1376 ± 241 | 1440 ± 263 | 1416 ± 219 | 0.3146 | | Esophageal varices degree (mild : no) | 21 : 44 | 24 : 41 | 26 : 39 | 0.6565 | | ICG R15 (%) | 19.2 ± 8.4 | 18.4 ± 9.1 | 20.3 ± 10.7 | 0.5167 | | Comorbidities | 11 | 10 | 8 | 0.7531 | | Diabetes | 3 | 3 | 2 | | | Hypertension | 5 | 4 | 3 | | | COPD | 1 | 0 | 2 | | | Others | 2 | 3 | 1 | | | ASA grade (I : II : III) | 41 : 16 : 8 | 44 : 17 : 4 | 38 : 19 : 8 | 0.6793 |
|
|
ICG R15, indocyanine green 15 min retention rate.
|
